Methohexital Sodium for Injection 500 mg
Avet Pharmaceuticals is recalling Methohexital Sodium for Injection 500 mg vials due to failed impurities and degradation specifications.
Healthcare providers should immediately examine their inventory, quarantine the affected vials, and discontinue use. Contact your distributor or the manufacturer for return and replacement instructions.
Recall at a glance
- Quantity recalled
- 4284 vials
Why it was recalled
Avet Pharmaceuticals is recalling Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vials due to failed impurities and degradation specifications. This product is an injectable anesthetic used in clinical settings.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Methohexital Sodium for Injection, USP
- Lot code
- 7000612A, 2028
- Strength
- 500 mg
- NDC / UPC
- NDC 23155-893-31
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Impurity or Degradation recalls
Editorial summary by Recall Canary · summary updated 2026-07-08 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification